<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">Valvular Heart Disease</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="1040" role="article" about="/commodorecompendium/valvular-heart-disease" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><div class="WordSection1">
<div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Valvular Heart Disease – Benjamin Palmer </span></span></span></b></span></span></span></span></p>
</div>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Background</span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Aortic Stenosis: Degenerative calcification of the aortic cusps, usually due to congenital disease (bicuspid), chronic deterioration, or previous rheumatic inflammation</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Aortic Insufficiency: Primary</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> valve disease (rheumatic disease, bicuspid aortic valve, infective endocarditis, syphilis) or primary aortic root disease (medial degeneration, aortic dissection, Marfan’s syndrome, bicuspid aortic valve, syphilis, non-syndromic familial)</span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Mitral Regurgitation: </span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Acute: endocarditis, papillary muscle rupture post-MI, trauma, chordal rupture/leaflet flail in the setting of mitral valve prolapse </span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Chronic: myxomatous degeneration, rheumatic fever, healed endocarditis, mitral annular calcification, HOCM with systolic anterior motion, dilated cardiomyopathy </span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Secondary (aka “functional”): 2/2 LV dilation/dysfunction w/ structurally normal MV</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Mitral Stenosis: Rheumatic fever is the leading cause of mitral stenosis worldwide</span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Calcific MS is more common in high income countries</span></span></span></span></span></span></li>
</ul>
</li>
</ul>
<p> </p>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Aortic stenosis</span></span></span></b></span></span></span></span></p>
</div>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Presentation</span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Angina, syncope, exertional dyspnea, heart failure</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">70 – 80 y/o symptoms; if bicuspid aortic valve expect 10-20 yrs earlier </span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Physical exam: </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Systolic crescendo-decrescendo murmur that radiates towards the carotids</span></span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Late peaking murmur, faint or absent S2, delayed carotid upstroke (suggest severe AS)</span></span></span></span></span></span></span></li>
</ul>
</li>
</ul>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="text-autospace:none"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Management</span></span></span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Definitive treatment is valve replacement, with the most common indication being symptomatic, severe aortic stenosis</span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Consult</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> cardiac surgery for determination of SAVR vs TAVR (often a multidisciplinary decision between cardiac surgery and TAVR team)</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">In </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">general</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">, high risk surgical patients benefit most from TAVR</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">VUMC:  If the pt is determined to be intermediate to high operative risk by Cardiac Surgery, they will often recommend contacting the TAVR team for evaluation</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Avoid rapid hemodynamic shifts and aggressive changes in preload or afterload</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Aim for normotension: avoid preferential vasodilators such as hydralazine or nitroglycerin </span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">significant vasodilation may </span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Times New Roman&quot;,serif">↓ </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">coronary filling pressures </span></span><span style="font-size:12.0pt"><span style="font-family:Wingdings"></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> myocardial ischemia</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Monitoring:</span></span></span></span></span></span></span>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Severe AS: TTE q 6-12 months; Moderate AS: TTE q 1-2 years; Mild AS: TTE q 3-5 years</span></span></span></span></span></span></span></li>
</ul>
</li>
</ul>
</div>
<p> </p>
<p style="margin-left:48px"> </p>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Aortic Regurgitation</span></span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Presentation</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Acute</span></span><b><i> </i></b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">AR: The LV cannot respond to increased volume to maintain stroke volume, and thus patient will present with pulmonary edema and cardiogenic shock</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Chronic AR</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">: More indolent presentation, often patient will develop symptoms of heart failure including DoE, followed by orthopnea, PND</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Physical exam: “Water-hammer” pulses, Quincke’s pulses, wide pulse pressure, laterally displaced PMI, high pitched “blowing” decrescendo murmur best heard at third intercostal space at left sternal border, Austin Flint murmur, S3</span></span></span></span></span>​​​​​​​</li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Acute</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> severe AR should be treated with prompt surgical repair</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Vasodilators</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> such as nitroprusside and diuretics can be used to stabilize patient</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Chronic</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> severe AR should undergo replacement if: </span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Class I indications: Symptomatic, LVEF &lt; 50%, or are undergoing other cardiac surgery </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">If LVEF &gt; or equal 50%, patients should be considered for surgery if LVESD &gt; 50 mm (class IIa) or LVEDD &gt; 65 mm (class IIb)</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Any patient with progressive AR, even if they do not meet criteria for severe AR, should consider valve replacement if undergoing cardiac surgery for other reasons </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Quick mnemonic: 50/50 rule</span></span></span></b></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Early</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> symptoms of exercise intolerance can be treated with diuretics</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Systolic</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> BP should also be controlled with goal SBP &lt; 140 in chronic AR</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Monitor</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> over time for development of depressed LVEF and/or LV dilation</span></span></span></span></span></span></li>
</ul>
<p style="margin-left:12px"> </p>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Mitral regurgitation</span></span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Presentation</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Isolated</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> chronic mild to moderate MR is typically only minimally symptomatic</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Pts</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> w/ severe chronic MR develop progressively worsening dyspnea, orthopnea, and PND</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Palpitations</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> may develop in the setting of new atrial fibrillation due to LA remodeling/dilation </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Acute</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> severe MR typically presents with flash pulmonary edema</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Holosystolic</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> murmur most prominent at the apex and radiating towards the axilla, frequently associated with S3 </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">In </span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">acute</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> severe MR, pulmonary congestion is typically present</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Murmur may be absent due to large regurgitant orifice/low velocity regurgitant jet</span></span></span></span></span></span></li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Acute severe MR should be treated with surgery</span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Utilize diuretic therapy and vasodilators such as nitroprusside as means to stabilize patient; Afterload reduction is key to promote forward flow</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Chronic</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> severe primary MR, <b>surgical repair</b> (favored over valve replacement)</span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Performed if patient develops symptoms (EF &gt; 30% class I, EF &lt; 30% class IIb)</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Asymptomatic patients if LVEF 30-59% or LVESD &gt; or equal 40 mm (class I)  </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">If EF &gt; or equal 60% and LVESD &lt; 40 mm, or new onset AF or PASP &gt; 50, can also consider repair in low-risk patient (class IIa). <b>Quick mnemonic: 60/40</b></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Secondary MR can consider MV repair with persistent class III-IV symptoms while on </span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">guideline</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> directed medical therapy </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">If </span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">HFrEF</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">, consider MitraClip after volume optimization (see HF section)</span></span></span></span></span></span></li>
</ul>
<p> </p>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Mitral Stenosis</span></span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Presentation</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Dyspnea and cough typically occur with activities that increase the flow and pressure gradient across the valve, such as tachy-arrhythmias</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">As the stenosis worsens, symptoms of PND and orthopnea develop  </span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Physical</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> exam: </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Accentuated S1, prominent P2 if pulmonary hypertension develops, opening snap heard at cardiac apex followed by low-pitched rumbling diastolic murmur</span></span></span></span></span></span></li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Varies between rheumatic MS and calcific MS; in general, intervention of calcific MS is very challenging and high risk</span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Severe</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">, symptomatic rheumatic MS: percutaneous mitral balloon commissurotomy (PMBC)</span></span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">​​​​​​​</span></span></span></span></span></span><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Surgical repair/replacement if pt failed PMBC or undergoing other cardiac surgery</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Intervention for calcific MS is higher risk and should be reserved only for severely symptomatic patients (in general, prognosis is poor: 5-year survival &lt;50%)</span></span></span></span></span></span>
<ul>
<li><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino"><span style="color:black">No role for commissurotomy with calcific MS, surgical valve replacement may be considered for severely symptomatic patients (technically challenging)</span></span></span></span></li>
</ul>
</li>
</ul>
</div>
</div>
</article>
</div>
</div>